ABSTRACT. A total of 23 Streptococcus gallolyticus strains, consisting of 12 strains from feces of healthy animals and 11 from clinical cases of human or cow mastitis milk, were examined genealogically. Four strains of S. bovis "biotype II/1" and 3 strains of S. equinus, the closely related organisms to S. gallolyticus, were also analyzed for outgroup comparison. Neither the amplified ribosomal DNA restriction analysis (ARDRA) nor the randomly amplified polymorphic DNA (RAPD) analysis that had been designed to recognize S. gallolyticus strains virulent in pigeons could differentiate clinical strains from the others of S. gallolyticus. No correspondence between the DNA profile in either analysis and the host animal species was detected.
Streptococcus gallolyticus, which includes strains formerly identified as "S. bovis biotye I" and "S. bovis biotype II/2", can be distinguished from other related taxa or biotypes (i.e. S. equinus, and S. bovis "biotype II/1"), based on not only the results of DNA-DNA reassociation experiments [12] but also by amplified ribosomal DNA restriction analysis (ARDRA) [15] . Recently, Schlegel et al. [16] have proposed reclassifying S. gallolyticus strains formerly designated as "S. bovis biotype II/1" and as "S. bovis biotype II/ 2", and "S. macedonicus" strains into 3 subspecies, S. gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. pasteurianus subsp. nov. and S. gallolyticus subsp. macedonicus subsp. nov, respectively. Most of the strains belonging to the former 2 subspecies can decarboxylate gallate as well as produce tannase, by which a hydrolyzable tannin (i.e. gallotannin) is hydrolyzed to release gallic acid, which is subsequently decarboxylated to pyrogallol [12] .
Although S. gallolyticus subsp. is often found in the gutmicroflora of various animals [13] , it has been reported to cause mastitis in cattle [7] , septicemia in pigeons [4] , and meningitis, sepsis and endocarditis in humans [3, 10, 14] . Devriese et al. [5] demonstrated that most S. gallolyticus strains isolated from clinical cases were distinct from those isolated from the alimentary tracts of ruminants by SDS-PAGE analysis of whole-cell proteins. With near fulllength 16S ribosomal DNA sequence analysis, Herrero et al. [8] claimed that "S. bovis biotype I" is associated with endocarditis and malignant and premalignant colon lesions.
Recently, several studies have been undertaken in order to identify clinical strains of S. gallolyticus with certain genotypes. Baele et al. [1] have reported that the RAPD analysis distinguished pigeon isolates of S. gallolyticus into levels of the virulence. We deal here with genotypic characterization of S. gallolyticus strains, by employing the ARDRA and RAPD [1, 15] analyses in order to evaluate a possible genotypic distinction between clinical and subclinical strains.
Twenty-three strains of S. gallolyticus including 4 strains of S. bovis "biotype II/1" and 3 strains of S. equinus were used in the present study. The origins of the strains and the results of their phenotypic identifications are summarized in Table 1 . For the genealogical analyses, whole genomic DNA from each isolate was prepared by the method of Marmur [11] .
The ARDRA analysis was performed by the method described by Schlegel et al. [15] . Briefly, PCR amplification targeting a partial sequence of the rrn genes including the 16S-23S intergenic spacer region was performed by means of a DNA thermal cycler (GeneAmp PCR System 2 70 0; A pp lied Bio system s) w ith prime rs Ad (5 '-AGAGTTTGATCMTGGCTCAG-3') and O24/3 (5'-CGA-CATCGAGGTGCCAAA-3'). The PCR products were then digested with one of the restriction endonucleases, HhaI, MboII or Sau3A. The restricted fragments were analyzed electrophoretically with 1.5% agarose gel and the fragment pattern was visualized by means of a UV illumination.
The ARDRA profiles of the strains are shown in Fig. 1 . Two major clusters were detected at a similarity level of 75% or less from the dendrogram generated. One of the clusters consisted of S. gallolyticus strains and another cluster consisted of S. bovis "biotype II/1" and S. equinus strains. The cluster group of S. gallolyticus strains was subdivided into 2 subgroups at approximately 75% similarity. These subgroups consisted of the strains of "S. bovis biotype I" and "S. bovis biotype II/2", respectively, assigned by the API system. Several 16S rDNA-based phylogenic analyses reported elsewhere [2, 8] have indicated that "S. bovis biotype II/2" is distinct from "S. bovis biotype I". The evidence obtained from our ARDRA analysis further substantiated this genotypic distinction since the analysis is designed to detect variations not only in 16S sequences but also in 23S and the 16S-23S intergenic spacer sequences. Within the cluster of S. gallolyticus, however, the analysis could not differentiate the strains of clinical origin from those of subclinical origin. The ARDRA patterns were also not related to difference in the host species.
The RAPD assay as a whole genome analysis was performed with an oligonucleotide primer, OPM6 (5'-CTGGGCAACT-3'), according to the method described by Baele et al. [1] with some modifications in the PCR conditions. Briefly, the reaction mixture was heated at 94°C for 5 min, 35°C for 5 min, and 72°C for 5 min prior to 30 cycles of PCR amplification. One PCR cycle consisted of denaturation at 94°C for 30 s, primer annealing at 35°C for 1 min, and extension at 72°C for 1 min. After the 30 cycles for the amplification, the temperature was maintained at 72°C for 5 min and then chilled to 4°C until the next examinations. The profiles of the amplified products detected by electrophoresis in 2% agarose gel were analyzed in the same manner as the ARDRA.
The RAPD profiles of the derived dendrogram are shown in Fig. 2 which was consisted of two intensified bands at 780 and 1,400 bp with several faint bands seldom found in avirulent strains of S. gallolyticus. Although the fragment patterns in the strains ACM 3849, ACM 3850 and ACM 3593 resembled those of the virulent pigeon strains, the majority of the RAPD profiles were noticeably heterogeneous. Thus there was no difference in the patterns between the clinical and subclinical strains. These facts suggest that the RAPD typing for distinguishing the virulence of S. gallolyticus strains cannot be generalized for the wider range of host animals. The RAPD profiles were also not related to difference in the host species. In the present study, neither the ARDRA nor the RAPD analysis differentiated the S. gallolyticus strains of clinical origins from subclinical. This does not necessarily imply that all S. gallolyticus found in a normal gut-microflora is potentially pathogenic. As demonstrated elsewhere [9] , clinical isolates have shown marked expression of an adhesion molecule sLe x on the cell surface compared to fecal isolates. It is therefore tempting to speculate that limited numbers of genes regulating expression of such a molecule may be the key to identifying pathogenic S. gallolyticus. Further study is in progress to evaluate this possibility. 
